Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rathore

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Exploring the Prominent and Concealed Inhibitory Features for Cytoplasmic Isoforms of Hsp90 Using QSAR AnalysisMagdi E A Zaki, Sami A Al-Hussain, Syed Nasir Abbas Bukhari, et al.
International Journal of Molecular Sciences|December 11, 2022
Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase BVijay H Masand, Sami A Al-Hussain, Mithilesh M Rathore, et al.
Oncogene|June 30, 2019
Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathwayM Rathore, C Girard, M Ohanna, et al.
JAMA|February 5, 2000
Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study TeamS A Nachman, K Stanley, R Yogev, et al.
The Journal of Infectious Diseases|November 9, 2000
Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study TeamW T Shearer, R J Israel, S Starr, et al.
Pediatrics|August 3, 2001
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infectionsD W Kimberlin, C Y Lin, R F Jacobs, et al.
Pediatrics|August 3, 2001
Natural history of neonatal herpes simplex virus infections in the acyclovir eraD W Kimberlin, C Y Lin, R F Jacobs, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Exploring the Prominent and Concealed Inhibitory Features for Cytoplasmic Isoforms of Hsp90 Using QSAR AnalysisMagdi E A Zaki, Sami A Al-Hussain, Syed Nasir Abbas Bukhari, et al.
International Journal of Molecular Sciences|December 11, 2022
Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase BVijay H Masand, Sami A Al-Hussain, Mithilesh M Rathore, et al.
Oncogene|June 30, 2019
Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathwayM Rathore, C Girard, M Ohanna, et al.
JAMA|February 5, 2000
Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study TeamS A Nachman, K Stanley, R Yogev, et al.
The Journal of Infectious Diseases|November 9, 2000
Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study TeamW T Shearer, R J Israel, S Starr, et al.
Pediatrics|August 3, 2001
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infectionsD W Kimberlin, C Y Lin, R F Jacobs, et al.
Pediatrics|August 3, 2001
Natural history of neonatal herpes simplex virus infections in the acyclovir eraD W Kimberlin, C Y Lin, R F Jacobs, et al.
Pageof 4